EDGAR Filing Documents for 0001157523-13-003332

Form 8-K - Current report:

SEC Accession No. 0001157523-13-003332

Filing Date

2013-07-16

Accepted

2013-07-16 06:45:37

Documents

Period of Report

2013-07-16

Items

Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	SUCAMPO PHARMACEUTICALS, INC. 8-K	a50670663.htm	8-K	16182
2	EXHIBIT 99.1	a50670663_ex991.htm	EX-99.1	5665
3	SLIDE 1	slide1.jpg	GRAPHIC	280077
4	SLIDE 2	slide2.jpg	GRAPHIC	356655
5	SLIDE 3	slide3.jpg	GRAPHIC	281015
6	SLIDE 4	slide4.jpg	GRAPHIC	233248
	Complete submission text file	0001157523-13-003332.txt		1609269

Mailing Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814

Business Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814 3019613400

Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33609 | Film No.: 13969313
SIC: 2834 Pharmaceutical Preparations